Indoco Remedies has entered into strategic distribution partnership with Clarity Pharma, UK. This partnership marks a significant milestone in Indoco’s history, as the company will launch around 20 products over the next 18 months through Clarity Pharma, its distributor in the UK. The Company will continue to supply all the products under existing B2B partnership to its clients.
Indoco is a fully integrated, research-oriented pharmaceutical company with a strong global presence. The Company’s turnover is $212 million with a human capital of over 6000 employees, including over 400 skilled scientists and field staff who are the strength of the organization. Clarity Pharma has over 25 years of experience in bringing products to market and now services over 4,000 Primary Healthcare customers.
Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1887.95 |
| Dr. Reddys Labs. | 1348.70 |
| Cipla | 1431.65 |
| Zydus Lifesciences | 1149.00 |
| Lupin | 2457.45 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: